INTRODUCTION {#sec1-1}
============

Cisplatin (cis-diamminedichloroplatinum II, CP) is a potent antitumor drug for a wide variety of tumors such as head, neck, lung, testis, ovary, and breast.\[[@ref1]\] CP leads to accumulation of platinum within the kidney and disturb renal tubular tissue and function.\[[@ref2]\] The renal dysfunction; renal toxicity induced by CP is involved tubular epithelial cell toxicity, apoptosis, vasoconstriction in the renal microvasculature, proinflammatory effects and activating mitogen-activated protein kinases.\[[@ref2][@ref3]\] The CP-induced nephrotoxicity is manifested by increased serum level of blood urea nitrogen (BUN) and creatinine (Cr) as well as various histological aspects of kidney tissue.

The weight of kidneys tissue is another aspect that may change in CP-induced nephrotoxicity. It is reported that in animals treated with CP, the normalized kidneys weight increased, and it was correlated with intensity of tissue damage.\[[@ref4][@ref5]\] Clinically, kidney tissue biopsy is an invasive procedure to evaluate the kidney damage that should be avoided in non-critical conditions hence the most available non-invasive parameters to evaluate the toxicity induced by drug such as CP is the serum level of BUN and Cr. The relationships between these non-invasive parameters with intensity of kidney tissue damage provide more knowledge to understand, to interpret, and to avoid the CP-induced nephrotoxicity. Therefore, in this study, we tried to demonstrate the relationship between the histopathology damage scores and the weight of kidneys, as well as the relationship between the BUN or Cr and kidneys damage and weight in a large number of Wistar rats.

MATERIALS AND METHODS {#sec1-2}
=====================

The investigation was performed on Wistar rats. The rats were housed at a temperature of 23-25°C. The rats had free access to water and rat chow, and they were acclimatized to this diet for at least 1 week prior to the experiment. The experimental procedures were approved in advance by the Isfahan University Medical Sciences Ethics Committee.

In past 3 years (from 2009 to 2012) that our teams in Water and Electrolytes Research Center have been worked in the different projects on CP and its nephrotoxicity side-effect, 227 (170-220 g) rats were studied; 40 rats did not treated with CP; normal, and 187 rats received CP (7 mg/kg, ip) as a single dose, and they sacrificed 1 week later. Based on the projects, the treated rats received different supplementations to protect against CP induced nephrotoxicity. At the end of the experiment, the kidney was removed and weighted rapidly. The levels of serum Cr and BUN were determined using the quantitative diagnostic kits (Pars Azmoon, Iran). The removed kidney was fixed in 10% neutral formalin solution and was embedded in paraffin for the histopathological staining. The hematoxylin and eosin, stain was applied to examine the tubular atrophy, cast, debris and necrotic material in the tubular lumen and lymphocytes in interstitial tissue were considered as damage in tubules. Based on the intensity of tubular lesions as mentioned above, we scored from 1 to 4 while the score of zero was assigned to normal tubules without damage.

Statistical analysis {#sec2-1}
--------------------

Statistical analysis was carried out with SPSS version 16. Data are expressed as mean ± SEM The serum levels of BUN, Cr and normalized kidney weight between each kidney tissue damage score were compared using one-way ANOVA. To obtain a relationship between BUN or Cr with normalized kidney weight, linear regression was applied. Values of *P* \< 0.05 were considered statistically significant.

RESULTS {#sec1-3}
=======

The relationship between the serum levels of BUN, Cr, or normalized kidneys weight and the pathology damage score are shown in [Figure 1](#F1){ref-type="fig"}. As pathology damage score increases, the serum levels of BUN and Cr, and the kidney weight increase. The normalized kidney weight also was correlated with the logarithmic scale of the serum level s of BUN and Cr significantly (*P* \< 0.05) \[[Figure 2](#F2){ref-type="fig"}\].

![The relationship between the serum levels of blood urea nitrogen, creatinine, or normalized kidneys weight and pathology damage score. The signs indicate a significant difference from (\*) score 0, (\#) score 1, (†) score 2, or (\$) score3, *P* \< 0.05](JRMS-18-370-g001){#F1}

![The relationship between the serum levels of blood urea nitrogen or creatinine (in logarithmic scale) with the normalized kidneys weight](JRMS-18-370-g002){#F2}

For Cr: Log (10 Cr) =0.239 (SE = 0.093, *P* = 0.011) + 0.924 KW (SE = 0.098, *P* = 0.00)

For BUN: Log BUN = 0.845(SE = 0.082, *P* = 0.00) + 0.995KW (SE = 0.086, *P* = 0.00)

DISCUSSION {#sec1-4}
==========

CP nephrotoxicity primarily causes tubulo interstitial lesions.\[[@ref6]\] In animal models CP damages the proximal tubules, specifically the S3 segment in the outer medulla.\[[@ref6][@ref7]\] Mitochondrial swelling and nuclear pallor occur in the distal nephron. The glomerulus has no obvious morphologic changes.\[[@ref8]\] In this report, the pathological damage in CP treated rats was in tubules, and a grading model based on the intensity of tubular lesions (tubular atrophy, cast, debris, and necrotic material in the tubular lumen and lymphocyte in interstitial tissue) was developed for report of tubular damage, and its intensity in CP treated experimental rats.

Our analysis showed that this grading model had a good and acceptable correlation with the serum BUN and Cr (in logarithmic scale) level in CP treated rats. This finding seems to be sufficient to suggest a comment for the clinician to collect the similar data from patients who are subjected for kidney biopsy to verify or reject the correlation between biochemical and the histopathological data in human subject.

In previous reports of CP nephrotoxicity, pathological damage after CP treatment had been reported;\[[@ref8][@ref9][@ref10]\] however, there were no scoring system for the report of intensity of CP induced pathological damage.

The toxic kidneys gain weight as the damage increase.\[[@ref5][@ref7][@ref11][@ref12]\] On the other hand in CP treated rats decrease in body weight had been reported,\[[@ref5][@ref11][@ref13]\] and polyuria is a well-known phenomenon.\[[@ref12]\] It seems that decrease in urine concentrating ability secondary to decrease in the papillary hyper tonicity is the main cause of decrease in body weight.\[[@ref14][@ref15]\] Therefore, the kidney gain weight is not induced by body weight change or urination process disturbance.

In accordance with the other reports with a small number of an experimental rats\[[@ref5][@ref11][@ref12][@ref13]\] in the present study, the normalized kidney weight in a large number of CP treated rats was increased as kidney damage increase \[[Figure 1](#F1){ref-type="fig"}\]. In conclusion, it seems that change in the normalized kidney weight could be a good predictor of the pathological damage in experimental models and a reliable predictor of increase in serum Cr and BUN as well.
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